⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL220514 | 0.85 | — | — | |
| SCHEMBL17223613 | 0.84 | — | — | |
| SCHEMBL27818478 | 0.82 | — | — | |
| SCHEMBL28334389 | 0.82 | — | — | |
| SCHEMBL28332402 | 0.82 | — | — | |
| SCHEMBL6154881 | 0.80 | CA2 (0.31) | — | |
| SCHEMBL10308652 | 0.80 | — | — | |
| SCHEMBL1533866 | 0.77 | — | — | |
| SCHEMBL6154613 | 0.74 | — | — | |
| SCHEMBL282710 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230344009-A1 | ELECTROLYTE FOR A LITHIUM SECONDARY BATTERY INCLUDING AN IONIC LIQUID CONTAINING AN ETHER FUNCTIONAL GROUP AND A LITHIUM SECONDARY BATTERY INCLUDING THE SAME | HYUNDAI MOTOR COMPANY (KR) | 2023-10-26 | — | — | US | disclosed |
| US-20230344009-A1 | ELECTROLYTE FOR A LITHIUM SECONDARY BATTERY INCLUDING AN IONIC LIQUID CONTAINING AN ETHER FUNCTIONAL GROUP AND A LITHIUM SECONDARY BATTERY INCLUDING THE SAME | HYUNDAI MOTOR COMPANY (KR) | 2023-10-26 | — | — | US | disclosed |
| US-20160145356-A1 | METHOD OF MODIFYING POLYMERS | METSÄ SPRING OY (FI) | 2016-05-26 | — | — | US | disclosed |
| US-20050182040-A1 | Benzamide derivatives | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2005-08-18 | — | — | US | disclosed |
| EP-1500643-A1 | BENZAMIDE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-6734205-B2 | SODIUM CHANNEL MODERATORS; CARDIOVASCULAR DISORDERS; ANTIDIABETIC AGENTS | SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) | 2004-05-11 | — | — | US | disclosed |
| US-20030018056-A1 | Substituted guanidine derivatives | SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1238971-A1 | SUBSTITUTED GUANIDINE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2002-09-11 | — | — | EP | disclosed |